Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

"Additional formulation work is planned for the inhaled delivery of brilacidin for prophylactic use, toward controlling infection in the nasal passage and lungs by leveraging brilacidin’s ability to inhibit SARS-CoV-2 by disrupting viral integrity and impacting viral entry. Such development efforts, if successful, may enable brilacidin to emerge as a particularly effective and differentiated antiviral by preventing and/or decreasing early infectivity due to SARS-CoV-2"

https://static1.squarespace.com/static/5715352e20c647639137f992/t/5f9b5de065b30770ea051cfd/1604017708904/Brilacidin+COVID-19+Manuscript+and+Supplemental+Information+fv+10.30.20.pdf




"A nasal spray that blocks the absorption of the SARS-CoV-2 virus has completely protected ferrets it was tested on, according to a small study released on Thursday by an international team of scientists. The study, which was limited to animals and has not yet been peer-reviewed, was assessed by several health experts at the request of The New York Times."
"The work has been underway for months by scientists from Columbia University Medical Center in New York, Erasmus Medical Center in the Netherlands and Cornell University in Ithaca, N.Y., The study was funded by the National Institutes of Health and the Columbia University Medical Center."

https://www.nytimes.com/2020/11/05/health/coronavirus-ferrets-vaccine-spray.html?action=click&module=RelatedLinks&pgtype=Article